Peptides DB
Research-centric peptide and protocol reference hub
Study 3 of 15Melanotan II literaturePubMed · Observational2024

Barbie drug identification: Not a child's play.

Melanotan II was found to have a purity of 30%, and its identification poses unique challenges due to its molecular weight and multi-charged characteristics.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the melanotan ii corpus
5
Preclinical
9
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study aimed to identify the characteristics of Melanotan II found in submitted samples. The analysis utilized HPLC-DAD, UHPLC-TOF-MS, and UPLC-MS-MS techniques. The purity of Melanotan II was determined to be 30%.

How much of this paper we could read: partial text (0.60). We had some abstract detail. Check the source for anything decisive. What this means →
30% purity of Melanotan II.2024

Abstract

The authors’ words, as PubMed supplied them

Various samples-including two vials with a pharmaceutical appearance-were submitted to the laboratory for identification. The aim of this work was to describe the unique characteristics observed during the analysis of the powder contained in the vial. Samples were submitted to HPLC-DAD, UHPLC-TOF-MS, and/or UPLC-MS-MS analysis. The majority of the samples were easily identified as standard drugs of abuse. The main difficulty lay in identifying the powder in the vials. No match was found in the library through HPLC-DAD analysis. Fortunately, the vials were labeled as "Melanotan II", although the UV spectrum was not available. Mass spectrometric analysis of melanotan II was challenging, as it is a small peptide with a molecular weight of 1024 Da, which is significantly heavier than classical drugs that the laboratory usually handles. As a result, mass spectrometer's parameters can be limited to detect masses up to 1000 Da. Additionally, melanotan II is multi-charged which is also unusual for compounds typically targeted in our daily work. Finally, the reference standard allowed us to confirm the identification with both instruments, and determine the purity of 30%. Melanotan II is not approved on the market due to safety concerns. It is used illegally mainly for tanning, explaining its nickname "Barbie drug". To conclude, analysis of melanotan II was challenging as it is heavy and doubly charged. Moreover, its UV spectrum was initially not available in the literature. The difficulties faced by forensic scientists in detecting this drug may explain its popularity on the illicit market.

Background

The paper addresses the identification of Melanotan II, a synthetic peptide known for its melanogenic properties. Previous research has highlighted its potential use in tanning and appetite suppression, but safety and regulatory concerns remain. This study is significant as it seeks to clarify the chemical identity and implications of Melanotan II in a broader context.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the Melanotan II corpus

DControlling mountain-type zoonotic visceral leishmaniasis in China: Current progress and challenges through a One Health lens.One health (Amsterdam, Netherlands) · 2026 · Average total score was 47.77/100 (range: 38.59-61.72).reviewDDirect photoreception by pituitary endocrine cells regulates hormone release and pigmentation.Science (New York, N.Y.) · 2025DLeptin enhances the intracellular thyroid hormone activation in skeletal muscle to boost energy balance.Cell metabolism · 2025ATebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.reviewBIntegrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis.Renal failure · 2026 · n=100000 · CERS2: OR = 1.246, p_SMR = 0.027reviewBAssessing nutritional risk and its association with mortality in ICU patients using the modified NUTRIC score: evidence from a tertiary care hospital.Annals of medicine · 2026 · n=584 · Adjusted odds ratio for low nutritional risk associated with mortality was 0.51 (95% CI 0.28-0.91).Human